FAR Biotech
Martin Martinov is the Founder and Managing Partner of Gradient Biomodeling LLC, as well as the Co-Founder and Chief Scientific Officer of FAR Biotech. Martin is also a Co-Founder of Luventix Inc. Martin holds a PhD in Molecular Biophysics from Florida State University and a Master of Science in Biotechnology from Sofia University St. Kliment Ohridski.
This person is not in any teams
This person is not in any offices
FAR Biotech
FAR Biotech is a preclinical, computational drug discovery company that focuses on hard-to-drug targets that have high scientific and commercial value. Founded by Dr Martin Martinov after 25 years in academia and industry -- and named after the Bulgarian word “far” that translates into “lighthouse” or “beacon” -- FAR seeks to shine a light on drug discovery in areas of high unmet clinical need. FAR's proprietary technology can more rapidly identify novel, structurally diverse, optimized, lead molecules that other approaches would not look for, let alone find. The key differentiator is FAR's complete and rigorous quantum mechanical representation of drug-target interactions -- which embeds the advantages of quantum similarity and multi-property optimization for hit and lead identification -- augmented by AI / machine learning & big data. FAR's quantum biomodelling platform has been validated preclinically across a number of therapeutic areas, including neurodegeneration, oncology and infectious diseases.